Abstract
Cysteine S-nitrosylation (SNO) has important physiological roles related to maintaining protein activity, influencing protein conformation, and signaling apoptotic pathways. In Alzheimer’s disease (AD), SNO can exhibit neuroprotective effects through the inhibition of detrimental enzyme activity. However, in AD SNO is also implicated in mitochondrial dysfunction, neuronal loss, impaired metabolism, and protein misfolding and aggregation. In order to better understand the beneficial and detrimental effects of SNO, SNO sites in disease states must first be characterized. This requires robust analytical methods for the identification and quantification of SNO-modified proteins. Additionally, detection of endogenous SNO modifications requires highly sensitive methods, as this modification exists in low concentrations. Here we describe oxidized cysteine-selective combined precursor isotopic labeling and isobaric tagging (OxcyscPILOT), a high-throughput method for the identification and quantification of endogenous peptide SNO sites relative to the entire cysteine proteome. Combining selective reduction and enrichment of SNO peptides with the cPILOT methodology extends multiplexing capabilities to 12 samples with TMT6 reagents, 20 samples with TMT10 reagents, and potentially greater with custom isobaric tags. Our goal is to provide the reader with step-by-step instructions to perform OxcyscPILOT through demonstration with mouse brain tissues.
References
Butterfield DA et al (2014) Mass spectrometry and redox proteomics: applications in disease. Mass Spectrom Rev 33(4):277–301
Lennicke C et al (2016) Redox proteomics: Methods for the identification and enrichment of redox-modified proteins and their applications. Proteomics 16(2):197–213
Foster MW, Hess DT, Stamler JS (2009) Protein S-nitrosylation in health and disease: a current perspective. Trends Mol Med 15(9):391–404
Verrastro I et al (2015) Mass spectrometry-based methods for identifying oxidized proteins in disease: advances and challenges. Biomol Ther 5(2):378–411
Couvertier SM, Zhou Y, Weerapana E (2014) Chemical-proteomic strategies to investigate cysteine posttranslational modifications. Biochim Biophys Acta 1844(12):2315–2330
García-Santamarina S, Boronat S, Hidalgo E (2014) Reversible cysteine oxidation in hydrogen peroxide sensing and signal transduction. Biochemistry 53(16):2560–2580
Gu L, Robinson RA (2016) Proteomic approaches to quantify cysteine reversible modifications in aging and neurodegenerative diseases. Proteomics Clin Appl 10(12):1159–1177
Meckler X et al (2010) Reduced Alzheimer’s disease β-amyloid deposition in transgenic mice expressing S-palmitoylation-deficient APH1aL and nicastrin. J Neurosci 30(48):6160–16169
López-Sánchez LM, López-Pedrera C, Rodríguez-Ariza A (2014) Proteomic approaches to evaluate protein s-nitrosylation in disease. Mass Spectrom Rev 33(1):7–20
Zhao QF, Yu JT, Tan L (2015) S-Nitrosylation in Alzheimer’s disease. Mol Neurobiol 51(1):268–280
Nakamura T, Lipton SA (2010) Preventing Ca2+-mediated nitrosative stress in neurodegenerative diseases: possible pharmacological strategies. Cell Calcium 47(2):90–97
Choi Y-B et al (2000) Molecular basis of NMDA receptor-coupled ion channel modulation by S-nitrosylation. Nat Neurosci 3(1):15–21
Forrester MT et al (2009) Detection of protein S-nitrosylation with the biotin-switch technique. Free Radic Biol Med 46(2):119–126
Riederer IM et al (2009) Ubiquitination and cysteine nitrosylation during aging and Alzheimer's disease. Brain Res Bull 80(4-5):233–241
Zahid S et al (2014) Differential S-nitrosylation of proteins in Alzheimer’s disease. Neuroscience 256:126–136
Wang S et al (2012) Two-dimensional nitrosylated protein fingerprinting by using poly (methyl methacrylate) microchips. Lab Chip 12(18):3362–3369
Wang S et al (2011) Highly sensitive detection of S-nitrosylated proteins by capillary gel electrophoresis with laser induced fluorescence. J Chromatogr A 1218(38):6756–6762
Zareba-Koziol M et al (2014) Global analysis of S-nitrosylation sites in the wild type (APP) transgenic mouse brain-clues for synaptic pathology. Mol Cell Proteomics 13(9):2288–2305
Wu C et al (2011) Distinction of thioredoxin transnitrosylation and denitrosylation target proteins by the ICAT quantitative approach. J Proteome 74(11):2498–2509
Chen CH et al (2015) Pin1 cysteine-113 oxidation inhibits its catalytic activity and cellular function in Alzheimer’s disease. Neurobiol Dis 76:13–23
Chouchani ET et al (2010) Identification of S-nitrosated mitochondrial proteins by S-nitrosothiol difference in gel electrophoresis (SNO-DIGE): implications for the regulation of mitochondrial function by reversible S-nitrosation. Biochem J 430(1):49–59
Forrester MT et al (2009) Proteomic analysis of S-nitrosylation and denitrosylation by resin-assisted capture. Nat Biotechnol 27(6):557–559
Su D et al (2013) Quantitative site-specific reactivity profiling of S-nitrosylation in mouse skeletal muscle using cysteinyl peptide enrichment coupled with mass spectrometry. Free Radic Biol Med 57:68–78
Pan KT et al (2014) Mass spectrometry-based quantitative proteomics for dissecting multiplexed redox cysteine modifications in nitric oxide-protected cardiomyocyte under hypoxia. Antioxid Redox Signal 20(9):1365–1381
Qu Z et al (2014) Proteomic quantification and site-mapping of S-nitrosylated proteins using isobaric iodoTMT reagents. J Proteome Res 13(7):3200–3211
Wojdyla K et al (2015) The SNO/SOH TMT strategy for combinatorial analysis of reversible cysteine oxidations. J Proteome 113:415–434
Gu L, Robinson RAS (2016) High-throughput endogenous measurement of S-nitrosylation in Alzheimer’s disease using oxidized cysteine-selective cPILOT. Analyst 141(12):3904–3915
Evans AR et al (2015) Global cPILOT analysis of the APP/PS-1 mouse liver proteome. Proteomics Clin Appl 9(9-10):872–884
Evans AR, Robinson RA (2013) Global combined precursor isotopic labeling and isobaric tagging (cPILOT) approach with selective MS(3) acquisition. Proteomics 13(22):3267–3272
Gu L, Evans AR, Robinson RA (2015) Sample multiplexing with cysteine-selective approaches: cysDML and cPILOT. J Am Soc Mass Spectrom 26(4):615–630
Gu L, Robinson RA (2016) A simple isotopic labeling method to study cysteine oxidation in Alzheimer’s disease: oxidized cysteine-selective dimethylation (OxcysDML). Anal Bioanal Chem 408(11):2993–3004
Ting L et al (2011) MS3 eliminates ratio distortion in isobaric multiplexed quantitative proteomics. Nat Methods 8(11):937–940
Acknowledgements
The authors would like to acknowledge the National Institutes of Health for financial support (R01 GM 117191-01).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Dyer, R.R., Gu, L., Robinson, R.A.S. (2017). S-Nitrosylation in Alzheimer’s Disease Using Oxidized Cysteine-Selective cPILOT. In: Santamaría, E., Fernández-Irigoyen, J. (eds) Current Proteomic Approaches Applied to Brain Function. Neuromethods, vol 127. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7119-0_14
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7119-0_14
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7118-3
Online ISBN: 978-1-4939-7119-0
eBook Packages: Springer Protocols